This randomized, double-blind, placebo-controlled, single ascending-dose study evaluated oral doses of the botanical kratom ...
The pharmacokinetics, safety, and tolerability of four topical lidocaine patches 5% continuously applied for 72 hours and changed every 12 or 24 hours were examined. In this randomized, prospective, ...
A phase I study of the tolerability, safety, pharmacokinetics and preliminary antitumor effects of KBP-5209, a novel pan-HER inhibitor, in patients with advanced solid tumors. The potential clinical ...
Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer Sixty-seven patients with metastatic solid tumors ...
Irrespective of what therapeutic area or drug target a discovery program pursues, a common bottleneck that cannot be avoided is pharmacokinetics and safety. Thus, all drugs must enter the body, ...
In this study, an UPLC-MS/MS method with specificity and accuracy was established to simultaneously quantify aumolertinib, osimertinib, gefitinib and their major metabolites (left). By using this ...
Discovering and bringing a new drug to market typically takes 14 years and costs approximately $ 2 billion USD. Today, the competitive landscape throughout the drug development process requires ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results